China Medical & HealthCare Group Past Earnings Performance
Past criteria checks 2/6
China Medical & HealthCare Group's earnings have been declining at an average annual rate of -15.4%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been growing at an average rate of 6.5% per year. China Medical & HealthCare Group's return on equity is 1.1%, and it has net margins of 0.7%.
Key information
-15.4%
Earnings growth rate
-14.8%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 6.5% |
| Return on equity | 1.1% |
| Net Margin | 0.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
China Medical & HealthCare Group's (HKG:383) Returns On Capital Not Reflecting Well On The Business
Feb 02
Returns On Capital Signal Difficult Times Ahead For China Medical & HealthCare Group (HKG:383)
Oct 26Is China Medical & HealthCare Group (HKG:383) Using Debt In A Risky Way?
Sep 30China Medical & HealthCare Group (HKG:383) Might Have The Makings Of A Multi-Bagger
Dec 10We Think China Medical & HealthCare Group (HKG:383) Has A Fair Chunk Of Debt
Apr 08Do Institutions Own China Medical & HealthCare Group Limited (HKG:383) Shares?
Feb 14
Is China Medical & HealthCare Group (HKG:383) A Risky Investment?
Dec 22Revenue & Expenses BreakdownBeta
How China Medical & HealthCare Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,569 | 11 | 237 | 0 |
| 30 Sep 23 | 1,516 | -35 | 247 | 0 |
| 30 Jun 23 | 1,463 | -81 | 258 | 0 |
| 31 Mar 23 | 1,450 | -103 | 258 | 0 |
| 31 Dec 22 | 1,438 | -124 | 259 | 0 |
| 30 Sep 22 | 1,464 | -115 | 245 | 0 |
| 30 Jun 22 | 1,491 | -107 | 231 | 0 |
| 31 Mar 22 | 1,477 | -122 | 228 | 0 |
| 31 Dec 21 | 1,463 | -137 | 225 | 0 |
| 30 Sep 21 | 1,447 | -127 | 232 | 0 |
| 30 Jun 21 | 1,430 | -116 | 238 | 0 |
| 31 Mar 21 | 1,312 | -114 | 233 | 0 |
| 31 Dec 20 | 1,194 | -112 | 228 | 0 |
| 30 Jun 20 | 1,099 | -81 | 238 | 0 |
| 31 Mar 20 | 1,163 | -40 | 240 | 0 |
| 31 Dec 19 | 1,228 | 1 | 243 | 0 |
| 30 Jun 19 | 1,196 | 35 | 246 | 0 |
| 31 Mar 19 | 1,168 | -8 | 245 | 0 |
| 31 Dec 18 | 1,139 | -52 | 243 | 0 |
| 30 Sep 18 | 1,120 | -94 | 246 | 0 |
| 30 Jun 18 | 1,101 | -137 | 248 | 0 |
| 31 Mar 18 | 1,115 | -198 | 249 | 0 |
| 31 Dec 17 | 1,130 | -258 | 249 | 0 |
| 30 Sep 17 | 1,207 | -165 | 245 | 0 |
| 30 Jun 17 | 1,284 | -72 | 241 | 0 |
| 31 Mar 17 | 1,791 | -143 | 251 | 0 |
| 31 Dec 16 | 2,297 | -214 | 261 | 0 |
| 30 Sep 16 | 2,349 | -498 | 243 | 0 |
| 30 Jun 16 | 2,400 | -783 | 225 | 0 |
| 31 Mar 16 | 1,787 | -375 | 195 | 0 |
| 31 Dec 15 | 1,175 | 33 | 165 | 0 |
| 30 Sep 15 | 945 | 131 | 153 | 0 |
| 30 Jun 15 | 715 | 228 | 141 | 0 |
| 31 Mar 15 | 859 | 233 | 197 | 0 |
| 31 Dec 14 | 1,003 | 237 | 253 | 0 |
| 30 Sep 14 | 1,050 | 582 | 232 | 0 |
| 30 Jun 14 | 1,096 | 928 | 211 | 0 |
| 31 Dec 13 | 219 | -363 | -4 | 0 |
| 30 Sep 13 | 80 | -541 | 12 | 0 |
| 30 Jun 13 | -59 | -718 | 27 | 0 |
Quality Earnings: 383 has a large one-off gain of HK$6.0M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 383 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 383 has become profitable over the past 5 years, growing earnings by -15.4% per year.
Accelerating Growth: 383 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 383 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (13.4%).
Return on Equity
High ROE: 383's Return on Equity (1.1%) is considered low.